NCT01761513View on ClinicalTrials.gov

YH4808 Postprandial PK/PD Study in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2014

Conditions
Healthy
Interventions
DRUG

YH4808

"Group1~1. adminitration of YH4808 dose1, bid for 2weeks~2. wash-out period for 3weeks between period1 and period2~3. adminitration of YH4808 dose2, qd for 2weeks"

DRUG

YH4808

"Group2~1. adminitration of YH4808 dose2, qd for 2weeks~2. wash-out period for 3weeks between period1 and period2~3. adminitration of YH4808 dose1, bid for 2weeks"

DRUG

YH4808

"Group3~1. adminitration of YH4808 dose2, bid for 2weeks~2. wash-out period for 3weeks between period1 and period2~3. adminitration of Nexium tab 40mg, bid for 2weeks"

DRUG

YH4808

"Group 4~1. adminitration of Nexium tab 40mg, bid for 2weeks~2. wash-out period for 3weeks between period1 and period2~3. adminitration of YH4808 dose2, bid for 2weeks"

Trial Locations (1)

120-752

Yonsei University Health System(Severance Hospital), Seoul

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT01761513 - YH4808 Postprandial PK/PD Study in Healthy Subjects | Biotech Hunter | Biotech Hunter